tiprankstipranks
MEDICLIN AG (DE:MED)
XETRA:MED
Holding DE:MED?
Track your performance easily

MEDICLIN (MED) Technical Analysis

1 Followers

Summary of all the Indicators

Overall Consensus
Buy
11Bullish
6Neutral
5Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
MEDICLIN AG’s (MED) Moving Averages Convergence Divergence (MACD) indicator is 0.05, suggesting MEDICLIN AG is a Sell.
MEDICLIN AG’s (MED) 20-Day exponential moving average is 2.52, while MEDICLIN AG’s (MED) share price is €2.56, making it a Buy.
MEDICLIN AG’s (MED) 50-Day exponential moving average is 2.47, while MEDICLIN AG’s (MED) share price is €2.56, making it a Buy.

MEDICLIN (MED) Pivot Points

Nov 25, 2024, 11:40 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.60
2.60
2.60
2.60
2.60
2.60
2.60
Fibonacci
2.60
2.60
2.60
2.60
2.60
2.60
2.60
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

MEDICLIN (MED) Moving Averages

Nov 25, 2024, 11:40 AM
Period
Simple
Exponential
MA5
2.59Sell
2.58Sell
MA10
2.56Sell
2.56Buy
MA20
2.49Buy
2.52Buy
MA50
2.42Buy
2.47Buy
MA100
2.46Buy
2.49Buy
MA200
2.56Buy
2.55Buy
MEDICLIN AG’s (MED) 10-Day exponential moving average is 2.56, while MEDICLIN AG’s (MED) share price is €2.56, making it a Buy.
MEDICLIN AG’s (MED) 100-Day exponential moving average is 2.49, while MEDICLIN AG’s (MED) share price is €2.56, making it a Buy.
MEDICLIN AG’s (MED) stock price is €2.56 and MEDICLIN AG’s (MED) 50-day simple moving average is 2.42, creating a Buy signal.
MEDICLIN AG’s (MED) stock price is €2.56 and MEDICLIN AG’s (MED) 100-day simple moving average is 2.46, creating a Buy signal.
MEDICLIN AG’s (MED) stock price is €2.56 and MEDICLIN AG’s (MED) 200-day simple moving average is 2.56, creating a Buy signal.

MEDICLIN (MED) Technical Indicators

Nov 25, 2024, 11:40 AM
Name
Value
Implied Action
RSI (14)
56.57
Neutral
STOCH (9,6)
58.12
Neutral
STOCHRSI (14)
64.77
Neutral
MACD (12,26)
0.05
Sell
ADX (14)
23.05
Neutral
Williams %R
-46.67
Buy
CCI (14)
35.09
Neutral
ATR (14)
0.08
-
Ultimate Oscillator
69.50
Neutral
ROC
5.79
Buy
MEDICLIN AG’s (MED) Relative Strength Index (RSI) is 56.57, creating a Neutral signal.
MEDICLIN AG’s (MED) Trend Strength Indicator (ADX) is 23.05, creating a Neutral signal.
MEDICLIN AG’s (MED) Commodity Channel Index (CCI) is 35.09, creating a Neutral signal.
MEDICLIN AG’s (MED) Price Rate of Change (ROC) is 5.79, creating a Buy signal.

FAQ

Is MED a Buy, Hold, or Sell?
Based on MED’s technical indicators, MED is a Buy.
    What is MED’s RSI (14)?
    MED’s RSI (14) is 56.57, which suggests MED is a Neutral.
      What is MED’s MACD?
      MED’s MACD is 0.05, which suggests MED is a Sell.
        What is MED’s 5-day moving average?
        MED’s 5-day moving average is 2.59, which suggests MED is a Sell.
          What is MED’s 20-day moving average?
          MED 20-day moving average is 2.49, which suggests MED is a Buy.
            What is MED’s 50-day moving average?
            MED’s 50-day moving average is 2.42, which suggests MED is a Buy.
              What is MED’s 200-day moving average?
              MED’s 200-day moving average is 2.56, which suggests MED is a Buy.
                What is MED’s Williams % R (14)?
                MED’s Williams % R (14) is -46.67, which suggests MED is a Buy.
                  What is MED’s CCI (14)?
                  MED’s CCI (14) is 35.09, which suggests MED is a Neutral.
                    What is the share price of MEDICLIN AG?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis